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The P2X7 receptor (P2X7R) is an important member of the P2X family of ligand-gated ion channels that respond to ATP as the 
endogenous agonist. Studies suggest that P2X7R plays a potentially pivotal role in a variety of physiological functions, including 
peripheral and central neuronal transmission, smooth muscle contraction, and inflammation. Thus, P2X7R may be a potential tar-
get for drug development. Here, we used a FlexStation to examine the function of recombinant P2X7R stably expressed in human 
embryonic kidney 293 cells and to compare three high-throughput screening assays: a membrane potential assay, an ethidium 
bromide uptake assay, and a calcium influx assay. We found that all three assays were suitable for the analysis of P2X7R, but the 
calcium influx assay was the most robust and is the best choice as a first high-throughput screening assay when embarking on a 
P2X7R drug discovery project. 
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The P2X7 receptor (P2X7R) belongs to the P2X family of 
ligand-gated ion channels. These channels respond to ATP 
(adenosine-5′-triphosphate) as the endogenous ligand and 
differ in their distribution, gating properties, and affinity for 
ATP and ATP analogs [1,2]. P2X7Rs are primarily ex-
pressed in epithelial cells and antigen-presenting cells such 
as lymphocytes, mast cells, and macrophages, where they 
exert immunomodulatory functions including inflammatory 
cytokine release, membrane fusion events, and apoptosis 
[3−5]. Most recently, the manufacture of several P2X7R 
antagonists with improved “drug-like” properties was re-
ported; for instance, AZD9056 has already entered Phase II 
clinical trials for rheumatoid arthritis [6−8]. A-740003 ex-
hibited preclinical efficacy as a P2X7R antagonist in rodent 
models of neuropathic pain [9]. These studies have sug-
gested that the P2X7R signaling pathway could be a thera-
peutic target for treating various neurodegenerative diseases, 
rheumatoid arthritis, and neuropathic pain [10−12]. 
Until now, there have been very limited options to meas-
ure the pharmacological properties of P2X7Rs. P2X7Rs re-
spond to brief (≤1 s) stimulation with extracellular agonist 
by the fast opening of an intrinsic cation-conducting pore, 
permitting the selective permeation of small cations (Na+, 
K+, and Ca2+) into the cell [13]. As a result, the plasma 
membrane depolarizes and the Na+ and K+ gradients col-
lapse. Both the actual ion influx and the change in mem-
brane potential can be exploited for the development of 
functional assays for P2X7R screening. 
The gold-standard technology to study ion channels is 
electrophysiology using whole-cell voltage-clamp record-
ings. It is sensitive and reliable, and offers the most accurate 
and high-content data. However, depending on many factors 
such as the cell type and the type of ion channel under study, 
patch clamping can be very labor-intensive and has a very 
low throughput. 
Fluorescent dyes sensitive to changes in membrane po-
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tential have been improved significantly during the last few 
years. The FLIPR system from Molecular Devices 
(Sunnyvale, CA, USA) can measure changes in membrane 
potential in high-throughput screening (HTS) format. The 
FLIPR system uses a 530-nm argon laser for excitation of 
the fluorescent dye that exhibits an increase in the emission 
intensity at 565 nm when the membrane depolarizes. 
Ion-specific fluorescent probes, such as calcium indicator 
dyes, are also available for measuring the ionic concentra-
tions in cells. A no-wash calcium assay kit from HD Bio-
sciences (Shanghai, China) can measure the fluorescent 
signal of calcium with a FlexStation system (Molecular De-
vices) or the FLIPR system in HTS format. 
A particular feature of P2X7Rs is that prolonged or re-
peated activation promotes the formation of large pores; 
these pores allow the bi-directional passage of molecules 
into the cell, as indicated by the entry of organic cations of 
up to 900 Da, and the leakage of metabolites [14,15]. Eth-
idium bromide (EtBr), a fluorescent, DNA-binding dye with 
a molecular weight of 314 Da, could enter through the di-
lated or “large-pore” form of the P2X7R and bind to intra-
cellular DNA/RNA, whereupon it increases its fluorescence 
intensity many fold. While this general method has been 
used to study P2X7R function in suspensions of cells in flu-
orimeter cuvettes, we have found that it is possible to per-
form this assay using cells in a 96-well plate, thus providing 
a relatively simple and robust functional assay for P2X7R 
screening in HTS format. 
Here we present data obtained from characterizing re-
combinant P2X7R expressed in human embryonic kidney 
(HEK) 293 cells. To select the best HTS assay to identify 
P2X7R ligands, we developed three HTS assays: a mem-
brane potential assay, an EtBr uptake assay, and a calcium 
influx assay. For pharmacological comparisons, we investi-
gated known P2X7R agonists in these three assays and 
compared the data to those from patch-clamp assays. Our 
results showed that all three HTS assays were suitable for 
the identification of P2X7R ligands, but the calcium influx 
assay was the most robust and is the most suitable for a first 
HTS assay when embarking on a P2X7R drug discovery 
project. 
1  Materials and methods 
1.1  Materials 
All cell culture media and supplements were obtained from 
Gibco (Invitrogen, Carlsbad, CA, USA), except fetal bovine 
serum, which was from Hyclone (Erembodegem-Aalst, 
Belgium). Blue membrane potential dye was purchased 
from Molecular Devices. The no-wash calcium assay kit 
was purchased from HD Biosciences. ATP, Bz-ATP 
(3′-O-(4-benzoyl)-benzoyl adenosine-5′-triphosphate) and 
the other chemicals were purchased from Sigma-Aldrich (St. 
Louis, MO, USA). 
1.2  Generation of a cell line stably expressing human 
P2X7Ri 
HEK 293 cells were cultured in Dulbecco’s modified Ea-
gle’s medium (with 4.5 mg/mL D-glucose) containing 2 
mmol/L glutamine and 10% fetal bovine serum. The cDNA 
encoding human P2X7R was synthesized based on the pub-
lished sequence (NCBI accession No. NM_002562) and 
inserted into the expression vector pCDNA3.1-hygro(+). 
Transfection of HEK 293 cells was performed using 
Lipofectamine™ (Invitrogen) according to the manufactur-
er’s instructions. Cells were incubated with the 
DNA-plus-Lipofectamine complex at 37°C for 24 h in a 
humidified 5% CO2 atmosphere. The cells were then pas-
saged into fresh culture medium and selected with 100 
g/mL hygromycin. Stable clones were grown in the same 
medium and were chosen based on their functional re-
sponses to Bz-ATP (10 mmol/L) in a Ca2+ influx assay. 
The cells were maintained in a 37°C incubator in a humidi-
fied 5% CO2 atmosphere. 
1.3  RT-PCR analysis 
Total RNA was isolated from HEK/hP2X7R cells using the 
RNA isolation reagent Trizol (Invitrogen) according to the 
manufacturer’s recommendations. For cDNA synthesis, 2 
g of total RNA was used in the RT reaction with 1 g of 
oligo (dT) primer, heated for 5 min at 70°C, and then 5× 
PCR buffer, 0.5 mmmol/L dNTP (dATP, dGTP, dCTP, and 
dTTP) mix, and 1 unit of RNase inhibitor were added and 
incubated at 42°C for 5 min. The 200 U of SuperScript II 
reverse transcriptase (Life Technologies, Carlsbad, CA, 
USA) were added, and the tube was incubated at 37°C for 
60 min. The reaction was then heated to 70°C to inactivate 
the reverse transcriptase. To amplify a 460-bp fragment of 
P2X7R, we used the forward primer 5′-TCACTGCCGTC- 
CCAAATACAGTTTCCG-3′ (nucleotide position 801–827) 
and the reverse primer 5′-TGCTGGTTCACCATCCTA- 
ATGTGGG-3′ (nucleotide position 1220–1244). 
1.4  Electrophysiology 
Whole cell recordings were made using an EPC10 patch- 
clamp amplifier and pulse acquisition programs (HEKA, 
Lambrecht, Germany). Patch pipettes (5–7 MΩ) contained 
154 mmol/L CsCl, 10 mmol/L EGTA, and 5 mmol/L 
HEPES. The “low divalent” extracellular solution contained 
147 mmol/L NaCl, 2 mmol/L KCl, 0.3 mmol/L CaCl2, 10 
mmol/L HEPES, and 12 mmol/L glucose. Agonists were 
delivered by a voltage command 8 pinch valve superfusion 
system (ALA Scientific Instruments, Farmingdale, NY, 
USA). Experiments were carried out at room temperature. 
1.5  Determination of membrane potential changes 
HEK 293 cells stably expressing hP2X7R were plated into 
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poly-D-lysine-coated 96-well clear-bottom black-walled 
plates (BD Biosciences, Bedford, MA, USA) at 40000 
cells/well in 100 L of growth medium and grown for 24 h 
prior to testing. Cells were washed with Hank’s balanced 
salt solution (Invitrogen) with 1 mmol/L MgCl2 and  1 
mmol/L CaCl2, leaving 50 L of buffer per well after the 
last wash. Blue membrane potential dye (50 L) was added, 
and the cells were incubated with dye for 45 min at 37°C. 
After incubation, the dye-loaded cell plate was placed in the 
FlexStation and the whole plate was imaged every 2 s (ex-
citation at 488 nm and emission at 550 nm); then after 20 s, 
agonist was added to the cells. To determine the effect of 
P2X7R blockers, cells were pretreated with compounds for 
5–10 min before the plate was transferred to the FlexStation. 
1.6  EtBr uptake analysis 
EtBr uptake was carried out as previously described [14] 
with some modifications. Briefly, HEK 293 cells stably 
expressing human P2X7R were harvested and seeded into 
poly-D-lysine-coated 96-well clear-bottom black-walled 
plates (BD Biosciences) at 20000 cells/well in 100 L cul-
ture medium, 24 h prior to the assay. Before the assay, the 
culture medium was removed and the cells were washed 
twice with dye uptake buffer (280 mmol/L sucrose, 5.6 
mmol/L KCl, 0.5 mmol/L CaCl2, 10 mmol/L glucose, 10 
mmol/L HEPES, and 5 mmol/L N-methyl-D-glucamine, pH 
7.4), then the cells were incubated in 100 L of dye uptake 
buffer containing 100 mol/L EtBr. Cells were subsequent-
ly treated with different concentrations of Bz-ATP (100 
L/well) prepared in dye uptake-EtBr buffer. After a 
30-min incubation, the EtBr uptake was monitored using a 
fluorometric imaging plate reader FlexStation with an exci-
tation wavelength of 525 nm and an emission wavelength of 
610 nm. Cells were pretreated with various concentrations 
of antagonists for 15 min at 37°C before the addition of 
Bz-ATP (10 mol/L). 
1.7  Determination of Ca2+ influx 
HEK 293 cells stably expressing hP2X7R were plated into 
poly-D-lysine-coated 96-well clear-bottom black-walled 
plates (BD Biosciences) at 40000 cells/well in 100 L 
growth medium and grown for 24 h prior to testing. The 
medium was removed and the cells were incubated for 1 h 
at 37°C in 100 L loading buffer (280 mmol/L sucrose, 5.6 
mmol/L KCl, 0.5 mmol/L CaCl2, 10 mmmol/L glucose, 10 
mmol/L HEPES, and 5 mmol/L N-methyl-D- glucamine, 
pH 7.4, and 1 mmol/L probenecid containing 1× calcium 
no-wash dye (HD Biosciences)). After incubation, the 
dye-loaded cell plate was placed in the FlexStation, and the 
whole plate was imaged every 2 s (excitation at 485 nm and 
emission at 525 nm); then after 20 s, 25 L of 5× agonist 
was added to the cells. To determine the effect of the P2X7R 
blockers, the cells were pretreated with compounds for 15 
min before the plate was transferred to the FlexStation. The 
fluorescent signal was quantitated in relative fluorescence 
units (RFU) as RFUmax – RFUmin over the 2-min run time. 
1.8  Data analysis 
Fluorescence signals in the Ca2+ influx assay were acquired 
for 90 s and then analyzed using SoftMax Pro software 
(version 4.8; Molecular Devices). The initial 10 s of the 
baseline were used to zero the signal, and the remaining 
signal was integrated using the area under the curve func-
tion. 
The EC50 and IC50 values were determined from eight- 
point concentration–response curves. All curve fittings were 
performed using GraphPad Prism version 4 software 
(GraphPad Software Inc., San Diego, CA, USA). The Z 
factor was calculated according to the method developed by 
[16] 
Z=1−3x(|SDpositive|+|SDnegtive|)/(|Meanpositive|−|Meannegative|), 
where SDpositive and SDnegative are the standard deviations of 
the positive and negative controls, respectively, and 
Meanpositive and Meannegative are the means of the positive and 
negative controls, respectively. 
2  Results and discussion 
2.1  Molecular analysis of the hP2X7R transcript 
While generating the stable HEK/hP2X7R cell lines, we first 
looked for the presence of mRNA expression of hP2X7R. 
The hP2X7R RT-PCR products migrated at 460 bp (Figure 
1). As predicted, after treatment with BamH I, the 460-bp 
PCR product was digested to 150- and 310-bp fragments. 
2.2  Electrophysiological properties of hP2X7R in HEK 
293 cells 
The expression of hP2X7R was also confirmed by whole- 
cell electrophysiological recordings. Brief application (1–3 s)  
 
 
Figure 1  Agarose gel electrophoresis (2% agarose) of RT-PCR products. 
A single 460-bp hP2X7R product was observed at the predicted position. 1: 
cDNA from wild-type HEK 293 cells; 2: cDNA from a HEK/hP2X7R 
stable cell line; 3: digestion of the 460-bp PCR product with BamH I. 
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of Bz-ATP to HEK 293 cells transfected with hP2X7R 
evoked inward currents (at –70 mV) and the EC50 value of 
Bz-ATP was 110 µmol/L (Figure 2). In non-transfected 
HEK 293 cells, application of a high concentration of Bz- 
ATP produced no significant inward currents (< 50 pA; data 
not shown). These results indicated that the transfected cell 
line expresses functional hP2X7R. 
2.3  Functional characterization of hP2X7R using  
a membrane potential assay 
The increase in Na+ influx associated with activation of 
hP2X7R causes a concomitant transient change in mem-
brane potential, which can be measured using fluorescent 
dyes sensitive to changes in membrane potential. The feasi-
bility of a membrane potential assay to identify hP2X7R 
channel function was explored using Molecular Devices’ 
blue membrane potential-sensitive dye detected with a 
FlexStation. Activation of hP2X7R channels with Bz-ATP 
resulted in an increase in fluorescent signal using membrane 
potential dye. Typical responses are shown in Figure 3. 
Both Bz-ATP and ATP caused a dose-dependent change in 
the fluorescent signal due to a hyperpolarization of the cel-
lular membrane with EC50 values of 27.3 µmol/L and 169.2 
µmol/L, respectively (Figure 4). The EC50 for Bz- ATP was 
lower than the values obtained using electrophysiological 
data; however, the agonists’ (ATP and Bz-ATP) rank order 
of potency was compatible with reference data [8]. 
2.4  Functional characterization of hP2X7R using an 
EtBr uptake assay 
Addition of agonist to cell suspensions of HEK 293 cells 
expressing hP2X7R caused a time- and concentration-  
dependent increase in EtBr fluorescence (Figure 5). This 
response was not observed in non-transfected HEK 293 
cells even when the cells were incubated in EtBr assay 
buffer for 1 h and stimulated with 50 µmol/L ATP. 
Next, we analyzed the dose responses of the three ago-
nists, Bz-ATP, ATP, and 2-MesATP. Both the efficacy of 
Bz-ATP, ATP, and 2-MesATP, and their rank order of po-
tency were compatible with reference data [14]. Among 
these agonists, Bz-ATP was the most potent, with an EC50 
of 4.22 mol/L; ATP was less potent, with an EC50 of 42.88 
mol/L; and 2-MesATP was the least potent, with an EC50 
of 85 mol/L (Figure 6). 
We also analyzed the dose responses of the specific 
hP2X7R blocker KN62 (1-[N,O-bis(1,5-isoquinolinesul- 
fonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine). The po-
tency of KN62 was compatible with reference data [14], 
with an IC50 value of 437 nmol/L (Figure 6(d)). 
2.5  Functional characterization of hP2X7R using  
a Ca2+ influx assay 
As a ion channel receptor, P2X7R can respond to extracel-
lular agonists by the fast opening of an intrinsic cation- 
conducting pore, permitting the selective permeation of  
 
 
Figure 2  Bz-ATP-activated currents in HEK 293 cells expressing hP2X7R. (a) Recording from one cell in response to application of nearly maximal con-
centrations of Bz-ATP in a solution containing 0.3 mmol/L CaCl2 and no magnesium (low divalents). (b) Concentration-response curves for 
Bz-ATP-induced currents in low divalent external solution. n=5 for each point. (c) Superimposed current traces obtained from one cell in response to the 
application of different concentrations of Bz-ATP. 
2816 Jiang Y Q, et al.   Chin Sci Bull   August (2013) Vol.58 No.23 
 
Figure 3  Typical hP2X7R FlexStation response in HEK 293 cells loaded with membrane potential dye. (○) Untransfected HEK 293 cells; (□) HEK 293 
cells stably expressing hP2X7R. Bz-ATP (100 µmol/L) was added at 16 s. 
 
Figure 4  Dose responses of compounds in the hP2X7R-expressing cell line. Assays were performed in duplicate and monitored with a FlexStation plate 
reader. See the Materials and Methods for details of the assay. (a) Bz-ATP; (b) ATP. The data points represent means ± SEM. EC50 values were determined 
using GraphPad Prism 4 software. 
 
Figure 5  Effect of agonist-stimulated increases in EtBr fluorescence in HEK/hP2X7R cells. (a) Fluorescent view of cells; (b) normal view of HEK/hP2X7R 
cells. 1: HEK/hP2X7R cells stimulated with 10 µmol/L 2-MesATP (2-methylthioadenosine triphosphate tetrasodium); 2: HEK/hP2X7R cells stimulated with 
10 µmol/L Bz-ATP; 3: HEK/hP2X7R cells stimulated with 50 µmol/L ATP; 4: dye uptake buffer only; 5: wild-type HEK 293 cells stimulated with       
50 µmol/L ATP. See the Materials and methods for details of the assay. 
small cations (Na+, K+, and Ca2+) into the cell. A no-wash 
calcium assay kit was used to measure the fluorescent signal 
of calcium with a FlexStation system. 
Activation of hP2X7R channels with Bz-ATP resulted in a 
seven- to nine-fold increase in fluorescent signal using a cal-
cium indicator dye. Typical responses are shown in Figure 7. 
We also analyzed the dose responses of the three agonists, 
Bz-ATP, ATP, and 2-MesATP. The potency of each was 
compatible with reference data [8]. Both the efficacy of 
Bz-ATP, ATP, and 2-MesATP, and their rank order of po-
tency were consistent with published data [8] and the results 
of the EtBr uptake assay. Among the agonists we tested, 
Bz-ATP was the most potent, with an EC50 of 10.54 mol/L; 
ATP was less potent, with an EC50 of 50.8 mol/L; and  
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Figure 6  Dose responses in an hP2X7R-expressing cell line. Assays were performed in duplicate and monitored with a FlexStation plate reader. See the 
Materials and methods for details of the EtBr uptake assay. (a) Bz-ATP; (b) ATP; (c) 2-MesATP; (d) KN62. The data points represent the means ± SEM. 
The EC50 or IC50 values were determined using GraphPad Prism 4 software. 
 
Figure 7  Typical hP2X7R FlexStation responses in HEK 293 cells loaded with calcium indicator dye. (□) Untransfected HEK 293 cells; (○) HEK 293 cells 
stably expressing hP2X7R. Bz-ATP (100 µmol/L) was added at 16 s. 
2-MesATP was the least potent, with an EC50 of less than 
55 mol/L (Figure 8). We also performed dose responses 
for the specific blocker hP2X7R KN62 using this Ca
2+ in-
flux assay. The potency of KN62 was compatible with ref-
erence data [9]; with an IC50 value of approximately 437 
nmol/L (Figure 8(d)). 
2.6  Evaluation of the Ca2+ influx assay in HTS format 
We found that all three fluorescent assays were suitable for 
analyzing hP2X7R, but the calcium influx assay was the 
most robust, considering the weak signals in the membrane 
potential assay and the extra dye-wash step required in the 
EtBr dye uptake assay. 
To show the robustness of the Ca2+ assay, the fluores-
cence signals for individual wells in a 96-well plate were 
plotted (Figure 9(b)). The average signals were 42.46 e5 ± 
2.27 e5 RFU for Bz-ATP and 4.29 e5 ± 0.32 e5 RFU for 
buffer (n=48). The calculated signal-to-background ratio 
was 19.36, and the Z factor was 0.796. 
The Z factor was also calculated in 10 consecutive 
96-well plates to assess inter-plate variation. Table 1 shows 
the Z factor for a 1-day run with 10 plates. The Z factors 
were very consistent between plates throughout the day. 
In summary, we investigated different fluorescent assay 
formats for studying hP2X7R: a membrane potential assay,  
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Figure 8  Dose responses of agonists in an hP2X7R-expressing cell line. Assays were performed in duplicate and monitored with a FlexStation plate reader. 
See Materials and Methods for details of the calcium influx assay. (a) Bz-ATP; (b) ATP; (c) 2-MesATP; (d) KN62. The data points represent the means ± 
SEM. The EC50 or IC50 values were determined using GraphPad Prism 4 software. 
 
Figure 9  Z factor determination in 96-well plate 
format. A HEK/hP2X7R cell line was stimulated 
with 30 mol/L Bz-ATP (EC100 as signal) and 
vehicle (0.2% dimethyl sulfoxide as background). 
(a) Raw data for the Z factor test; (b) Scatter plot 
of the data. See Materials and methods for details 
of the calcium influx assay. The calcium signal 
detection time for each column was 80 s. 
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Table 1  Individual plate Z factors in 10 consecutive 96-well plates a) 
Plate No. 1 2 3 4 5 6 7 8 9 10 
Z factor 0.834 0.898 0.874 0.861 0.908 0.882 0.831 0.866 0.793 0.870 
a) HEK/hP2X7R cells were plated in 10 consecutive 96-well plates. Vehicle (0.2% dimethyl sulfoxide) and 30 µmmol/L Bz-ATP (EC100) were applied to 
obtain the background and the signal readings, respectively. The Z factor was calculated for each individual plate. See Materials and methods for details of 
the calcium influx assay. The calcium signal detection time for each column was 80 s. 
 
 
a dye uptake assay and a Ca2+ influx assay. Similar phar-
macological properties were observed for hP2X7R-express- 
ing HEK 293 cells in these three fluorescent assays. How-
ever, the Ca2+ influx assay gave a much bigger assay win-
dow than the membrane potential assay, and required fewer 
steps than the EtBr uptake assay. The Ca2+ influx assay 
performance was very consistent and there was little varia-
tion in Z factor and Signal/Background from plate to plate 
and from day to day. The Ca2+ influx assay enabled us to 
embark on a P2X7R drug discovery project. 
 
 
1 North R A. Molecular physiology of P2X receptors. Physiol Rev, 
2002, 2: 1013–1067 
2 North R A. Pharmacology of cloned P2X receptors. Annu Rev Phar-
macol Toxicol, 2000, 40: 563–580 
3 Davide F, Cinzia P, Elena A, et al. The P2X7 receptor: A key player 
in IL-1 processing and release. J Immunol, 2006, 176: 3877–3883 
4 Korngreen A, Ma W, Priel Z, et al. Extracellular ATP directly gates a 
cation-selective channel in rabbit airway ciliated epithelial cells. J 
Physiol, 1988, 508: 703–720 
5 Taylor A L, Schwiebert L M, Smith J J, et al. Epithelial P2X puriner-
gic receptor channel expression and function. J Clin Invest, 1999, 104: 
875–884 
6 Baxter A, Bent J, Bowers K, et al. Hit-to-lead studies: The discovery 
of potent adamantane amide P2X7 receptor antagonists. Bioorg Med 
Chem Lett, 2003, 22: 4047–4050 
7 Donnelly-Roberts D L, Jarvis M F. Discovery of P2X7 receptor selec-
tive antagonists offers new insights into P2X7 receptor function and 
indicates a role in chronic pain states. Br J Pharmacol, 2007, 151: 
571–580 
8 Gever J R, Cockayne D A, Dillon M P, et al. Pharmacology of P2X 
channels. Pflugers Arch, 2006, 452: 513–537 
9 Honore P, Donnelly R D, Namovic M T, et al. A-740003 [N-  
(1-{[(cyanoimino) (5-quinoli-nylamino) methyl]amino}-2,2-dime- 
thylpropyl)-2-(3,4-dimethoxyphenyl) acetamide], a novel and selec-
tive P2X7 receptor antagonist, dose-dependently reduces neuropathic 
pain in the rat. J Pharmacol Exp Ther, 2006, 319: 1376–1385 
10 King B F. Novel P2X7 receptor antagonists ease the pain. Br J Phar-
macol, 2007, 151: 565–567 
11 Stephen D S, Patrizia D, Pietro G. The P2X7 purinergic receptor: 
From physiology to neurological disorders. FASEB J, 2010, 24: 337– 
345 
12 Khakh B S, North R A. P2X receptors as cell-surface ATP sensors in 
health and disease. Nature, 2006, 442: 527–532 
13 Surprenant A, North R A , Buell G, et al. The cytolytic P2Z receptor 
for extracellular ATP identified as a P2X receptor (P2X7). Science, 
1996, 272: 735–738 
14 Chessell I P, Michel A D, Humphrey P P. Properties of the 
poreforming P2X7 purinoceptor in mouse NTW8 microglial cells. Br 
J Pharmacol, 1997, 121: 1429–1437 
15 Hickman S E, E L Khoury J, Greenberg S, et al. P2Z adenosine tri-
phosphate receptor activity in cultured human monocyte-derived 
macrophages. Blood, 1994, 84: 2452–2456 
16 Zhang J H, Chung T D, Oldenburg K R. A Simple statistical parame-
ter for use in evaluation and validation of high throughput screening 
assays. J Biomol Screen, 1999, 4: 67–73 
 
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction 
in any medium, provided the original author(s) and source are credited. 
